Pini Orbach - 18 Oct 2023 Form 3/A - Amendment Insider Report for Ayala Pharmaceuticals, Inc.

Role: Director
Signature: /s/ Roy Golan, as attorney-in-fact for the Reporting Person
Issuer symbol: N/A
Transactions as of: 18 Oct 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 03 Nov 2023, 11:45:26 UTC
Date Of Original Report: 01 Nov 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney